- Home
- NERV vs WKHS Comparison
NERV vs WKHS Comparison
Compare NERV & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- WKHS
- Stock Information
- Founded
- NERV 2007
- WKHS 2007
- Country
- NERV United States
- WKHS United States
- Employees
- NERV N/A
- WKHS N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- WKHS Auto Manufacturing
- Sector
- NERV Health Care
- WKHS Consumer Discretionary
- Exchange
- NERV Nasdaq
- WKHS Nasdaq
- Market Cap
- NERV 14.6M
- WKHS 17.4M
- IPO Year
- NERV 2014
- WKHS N/A
- Fundamental
- Price
- NERV $3.78
- WKHS $0.86
- Analyst Decision
- NERV Hold
- WKHS Hold
- Analyst Count
- NERV 1
- WKHS 2
- Target Price
- NERV $4.00
- WKHS $8.68
- AVG Volume (30 Days)
- NERV 101.0K
- WKHS 4.2M
- Earning Date
- NERV 11-05-2025
- WKHS 11-10-2025
- Dividend Yield
- NERV N/A
- WKHS N/A
- EPS Growth
- NERV N/A
- WKHS N/A
- EPS
- NERV N/A
- WKHS N/A
- Revenue
- NERV N/A
- WKHS $10,620,296.00
- Revenue This Year
- NERV N/A
- WKHS $92.70
- Revenue Next Year
- NERV N/A
- WKHS $34.00
- P/E Ratio
- NERV N/A
- WKHS N/A
- Revenue Growth
- NERV N/A
- WKHS 16.73
- 52 Week Low
- NERV $1.15
- WKHS $0.53
- 52 Week High
- NERV $12.46
- WKHS $15.75
- Technical
- Relative Strength Index (RSI)
- NERV 49.13
- WKHS 48.17
- Support Level
- NERV $3.76
- WKHS $0.53
- Resistance Level
- NERV $4.42
- WKHS $1.08
- Average True Range (ATR)
- NERV 0.32
- WKHS 0.15
- MACD
- NERV -0.09
- WKHS 0.03
- Stochastic Oscillator
- NERV 25.93
- WKHS 60.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.